These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 37081710)

  • 1. Image-guided percutaneous locoregional therapies for hepatocellular carcinoma.
    Chevallier O; Zhao K; Marinelli B; Yarmohammadi H
    Chin Clin Oncol; 2023 Apr; 12(2):17. PubMed ID: 37081710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal hepatocellular carcinoma: a narrative review assessing treatment options from the interventional radiologist's perspective.
    Narayanan A; Garza-Berlanga A; Lopera J
    Ann Palliat Med; 2023 Nov; 12(6):1244-1259. PubMed ID: 37574584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Locoregional Therapies for Liver Cancer: Radiation Segmentectomy.
    Dadrass F; Sher A; Kim E
    Curr Oncol; 2023 Nov; 30(12):10075-10084. PubMed ID: 38132366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
    Han K; Kim JH
    World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma.
    Xu Z; Xie H; Zhou L; Chen X; Zheng S
    Anal Cell Pathol (Amst); 2019; 2019():8619096. PubMed ID: 31534899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
    Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
    Trials; 2012 Aug; 13():144. PubMed ID: 22913492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hepatocellular in the United States.
    Mokdad AA; Hester CA; Singal AG; Yopp AC
    Chin Clin Oncol; 2017 Apr; 6(2):21. PubMed ID: 28482674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial therapies in patients with hepatocellular carcinoma eligible for transarterial embolization: a US cost-effectiveness analysis.
    Patel MV; Davies H; Williams AO; Bromilow T; Baker H; Mealing S; Holmes H; Anderson N; Ahmed O
    J Med Econ; 2023; 26(1):1061-1071. PubMed ID: 37632520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment algorithms for managing hepatocellular carcinoma.
    Saraswat VA; Pandey G; Shetty S
    J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S80-9. PubMed ID: 25755616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transarterial ablative therapy of hepatocellular carcinoma].
    Mahnken AH
    Radiologe; 2014 Jul; 54(7):685-93. PubMed ID: 25047524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment.
    Kim AR; Park E; Kwon SY; Park SJ; Kim YJ; Yoo BC; Choe WH; Kim JH; Hwang JH; Park SW; Kim YJ; Park HS; Yu MH; Jeon HJ
    Korean J Gastroenterol; 2019 Mar; 73(3):167-176. PubMed ID: 31013560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.
    Hirooka M; Hiraoka A; Ochi H; Kisaka Y; Joko K; Michitaka K; Hiasa Y
    AJR Am J Roentgenol; 2018 Apr; 210(4):891-898. PubMed ID: 29412017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
    Shuanggang C; Shen L; Qiu Z; Qi H; Cao F; Xie L; Fan W
    J Cancer Res Ther; 2020; 16(2):250-257. PubMed ID: 32474509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
    Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
    BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New concepts in embolotherapy of HCC.
    Pesapane F; Nezami N; Patella F; Geschwind JF
    Med Oncol; 2017 Apr; 34(4):58. PubMed ID: 28299645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma.
    Thornton LM; Cabrera R; Kapp M; Lazarowicz M; Vogel JD; Toskich BB
    Curr Probl Diagn Radiol; 2017; 46(6):402-409. PubMed ID: 28392205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on Percutaneous Local Ablative Procedures for the Treatment of Hepatocellular Carcinoma.
    Luerken L; Haimerl M; Doppler M; Uller W; Beyer LP; Stroszczynski C; Einspieler I
    Rofo; 2022 Oct; 194(10):1075-1086. PubMed ID: 35545102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic response translates to improved patient survival after locoregional treatment for hepatocellular carcinoma: the importance of minimally invasive microwave ablation.
    Baimas-George M; Watson M; Sulzer J; Salibi P; Murphy KJ; Levi D; Martinie JB; Vrochides D; Baker EH; Ocuin L; Iannitti DA
    Surg Endosc; 2021 Jun; 35(6):3122-3130. PubMed ID: 32588344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-directed therapy for hepatocellular carcinoma.
    Narsinh KH; Duncan DP; Newton IG; Minocha J; Rose SC
    Abdom Radiol (NY); 2018 Jan; 43(1):203-217. PubMed ID: 29230556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.